Nisa Investment Advisors, LLC Myriad Genetics Inc Transaction History
Nisa Investment Advisors, LLC
- $25.4 Billion
- Q3 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 7,120 shares of MYGN stock, worth $56,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,120
              Previous 5,773
              
        
           23.33%
        
      
          
        Holding current value
$56,248
            Previous $30,000
            
        
           70.0%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  25 transactions
	
  Others Institutions Holding MYGN
# of Institutions
234Shares Held
95.5MCall Options Held
460KPut Options Held
14.2K- 
    
      Black Rock Inc. New York, NY15.2MShares$120 Million0.01% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA9.26MShares$73.1 Million0.0% of portfolio
- 
    
      Israel Englander Millennium Management LLC | New York, Ny4.92MShares$38.9 Million0.01% of portfolio
- 
    
      State Street Corp Boston, MA4.81MShares$38 Million0.0% of portfolio
- 
    
      Glenview Capital Management, LLC New York, NY4.59MShares$36.2 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $637M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...